Corbus Pharmaceuticals Reports 2016 Financial Results and Provides 2017 Business Update

10Mar

Corbus Pharmaceuticals Reports 2016 Financial Results and Provides 2017 Business Update

Portfolio News

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) („Corbus” or the „Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today its financial results for the year ended December 31, 2016. Read more >>

Share this post

Related Posts

25Jan

Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and the Massachusetts Life Sciences... read more
02Jul

Best Canned Wine Brands: Top 5 Delicious Blends, According To Expert

Wine belongs in a bottle, many thought, and still think. But then there are those that aren’t satisfied with the... read more
10May

INVEST Pitch Perfect winner: myBiometry aims to prevent asthma attacks long before they happen

Nationwide, more than 25 million people have asthma, including about 20 million adults and 5.1 million children and adolescents. If... read more
17Nov

Sysmex Selects Aras Innovator PLM

Aras, the next leader in enterprise product lifecycle management (PLM) software, announced Sysmex Corp., a leading international manufacturer of laboratory... read more
08Aug

Corbus Pharmaceuticals to Present New Data from Systemic Sclerosis Phase 2 Study of Anabasum at the 15th International Workshop on Scleroderma Research

Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory... read more
11Aug

You Now Have More Time to Repay Student Loans. Here’s How to Take Advantage of This ‘Fantastic Opportunity’

If you have federal student loan debt, you now have approximately six months to prepare for payments on that debt... read more
03Dec

Skyline Medical Names Carl Schwartz Chief Executive Officer, Appoints Richard Gabriel to Board of Directors

Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal,... read more
23Jun

Savvy Shopper: How to save money when buying toys

Let’s face it, toys are expensive. But they help to stimulate, educate, and occupy our busy kids when we need... read more
21May

Wasabi Raises Additional $25M in Funding, Led by Prosperity7 Ventures, and Extends Series C to $137M in Financing

Wasabi, the hot cloud storage company, today announced $25 million in additional funding led by Prosperity7 Ventures, the diversified growth... read more
14Feb

Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO

Windgap Medical announced today it has appointed Aaron Mann as the company's Chief Executive Officer and Michael Samar as the... read more